Back to today’s briefing

Story perspectives

Trump Administration Revamps COVID Booster Strategy for Seniors

5/23/2025

45 8

Summary

Story summary

The Trump Administration is shifting its approach to COVID-19 booster shots, now focusing approvals on seniors and high-risk individuals while awaiting further data. This new FDA framework demands rigorous studies for vaccines aimed at healthier populations, sparking worries about access for those eager for fall vaccinations, contrasting with earlier recommendations for annual shots for all.

1 of 1

Story summary

The Trump Administration is shifting its approach to COVID-19 booster shots, now focusing approvals on seniors and high-risk individuals while awaiting further data. This new FDA framework demands rigorous studies for vaccines aimed at healthier populations, sparking worries about access for those eager for fall vaccinations, contrasting with earlier recommendations for annual shots for all.